Structure and Function of Tumor Necrosis Factor (TNF) at the Cell Surface

Handbook of Cell Signaling, Second Edition

Volumn 1, Issue , 2009, Pages 265-275

  Wu, Hao ^a   Hymowitz, Sarah G ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880424215     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374145-5.00040-1     Document Type: Chapter

References (118)

1. CA Smith, T Farrah and RG Goodwin (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76 959-962.
2. LA Gravestein and J Borst (1998) Tumor necrosis factor receptor family members in the immune system. Sem Immunol 10 423-434.
3. RM Locksley, N Killeen and MJ Lenardo (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 487-501.
4. A Ashkenazi and VM Dixit (1998) Death receptors: signaling and modulation. Science 281 1305-1308.
5. WAM Leonen (1998) Editorial overview: CD27 and (TNFR) relatives in the immune system: their role in health and disease. Sem Immunol 10 417-422.
6. RC Newton and CP Decicco (1999) Therapeutic potential and strategies for inhibiting tumor necrosis factor-a. J Med Chem 42 2295-2314.
7. WB Coley (1893) The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci 105 487-511.
8. EA Carswell, LJ Old, RL Kassel, S Green, N Fiore and B Williamson (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72 3666-3670.
9. D Pennica, GE Nedwin, JS Hayflick, PH Seeburg, R Derynck, MA Palladino, WJ Kohr, BB Aggarwal and DV Goeddel (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312 724-729.
10. AM Wang, AA Creasey, MB Ladner, LS Lin, J Strickler, JN Van Arsdell, R Yamamoto and DF Mark (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228 149-154.
11. T Shirai, H Yamaguchi, H Ito, CW Todd and RB Wallace (1985) Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature 313 803-806.
12. B Beutler and A Cerami (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320 584-588.
13. DV Goeddel, BB Aggarwal, PW Gray, DW Leung, GE Nedwin, MA Palladino, JS Patton, D Pennica, HM Shepard, BJ Sugarman, et al. (1986) Tumor necrosis factors: gene structure and biological activities. Cold Spring Harb Symp Quant Biol 51(Pt 1), 597-609.
14. W Fiers (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Letts 285 199-212.
15. M Lewis, LA Tartaglia, A Lee, GL Bennett, GC Rice, GH Wong, EY Chen and DV Goeddel (1991) Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88 2830-2834.
16. JL Bodmer, P Schneider and J Tschopp (2002) The molecular architecture of the TNF superfamily. Trends Biochem Sci 27 19-26.
17. SG Hymowitz, DM Compaan, M Yan, HJ Wallweber, VM Dixit, MA Starovasnik and AM de Vos (2003) The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificity. Structure 11 1513-1520.
18. M Karpusas, TG Cachero, F Qian, A Boriack-Sjodin, C Mullen, K Strauch, YM Hsu and SL Kalled (2002) Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. J Mol Biol 315 1145-1154.
19. Y Liu, L Xu, N Opalka, J Kappler, HB Shu, G Zhang, et al. (2002) Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell 108 383-394.
20. DA Oren, Y Li, Y Volovik, TS Morris, C Dharia, K Das, O Galperina, R Gentz and E Arnold (2002) Structural basis of BLyS receptor recognition. Nature Struct Biol 9 288-292.
21. HJ Wallweber, DM Compaan, MA Starovasnik and SG Hymowitz (2004) The crystal structure of a proliferation-inducing ligand, APRIL. J Mol Biol 343 283-290.
22. K Chattopadhyay, et al. (2006) Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein. J Immunol 177 3920-3929.
23. DM Compaan and SG Hymowitz (2006) The crystal structure of the costimulatory OX40–OX40L complex. Structure 14 1321-1330.
24. Z Zhou, Y Tone, X Song, K Furuuchi, JD Lear, H Waldmann, M Tone, MI Greene and R Murali (2008) Structural basis for ligand-mediated mouse GITR activation. Proc Natl Acad Sci USA 105 641-645.
25. K Chattopadhyay, UA Ramagopal, A Mukhopadhaya, VN Malashkevich, TP Dilorenzo, M Brenowitz, SG Nathenson and SC Almo (2007) Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: implications for function. Proc Natl Acad Sci USA 104 19,452-19,457.
26. K Chattopadhyay, UA Ramagopal, M Brenowitz, SG Nathenson and SC Almo (2008) Evolution of GITRL immune function: murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily. Proc Natl Acad Sci USA 105 635-640.
27. JH Naismith and SR Sprang (1998) Modularity in the TNF-receptor family. Trends Biochem Sci 23 74-79.
28. SC Graham, MW Bahar, NG Abrescia, GL Smith, DI Stuart and JM Grimes (2007) Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J Mol Biol 372 660-671.
29. SG Hymowitz, DR Patel, HJ Wallweber, S Runyon, M Yan, J Yin, SK Shriver, NC Gordon, B Pan, NJ Skelton, RF Kelley and MA Starovasnik (2005) Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280 7218-7227.
30. DW Banner, A D’Arcy, W Janes, R Gentz, JJ Schoenfeld, C Broger, H Loetscher and W Lesslauer (1993) Crystal structure of the soluble human 55-kD TNF receptor–human TNF-β complex: implications for TNF receptor activation. Cell 73 431-445.
31. SS Cha, BJ Sung, YA Kim, YL Song, HJ Kim, S Kim, MS Lee and BH Oh (2000) Crystal structure of TRAIL–DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity. J Biol Chem 275 31,171-31,177.
32. SG Hymowitz, HW Christinger, G Fuh, M Ultsch, M O’Connell, RF Kelley, A Ashkenazi and AM de Vos (1999) Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4 563-571.
33. J Mongkolsapaya, JM Grimes, N Chen, XN Xu, DI Stuart, EY Jones and GR Screaton (1999) Structure of the TRAIL–DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nature Struct Biol 6 1048-1053.
34. HM Kim, KS Yu, ME Lee, DR Shin, YS Kim, SG Paik, OJ Yoo, H Lee and JO Lee (2003) Crystal structure of the BAFF–BAFF-R complex and its implications for receptor activation. Nature Struct Biol 10 342-348.
35. Y Liu, X Hong, J Kappler, L Jiang, R Zhang, L Xu, CH Pan, WE Martin, RC Murphy, HB Shu, S Dai and G Zhang (2003) Ligand–receptor binding revealed by the TNF family member TALL-1. Nature 423 49-56.
36. FK Chan, HJ Chun, L Zheng, RM Siegel, KL Bui and MJ Lenardo (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288 2351-2354.
37. RM Siegel, JK Frederiksen, DA Zacharias, FK Chan, M Johnson, D Lynch, RY Tsien and MJ Lenardo (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288 2354-2357.
38. M Rothe, SC Wong, WJ Henzel and DV Goeddel (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75-kDa tumor necrosis factor receptor. Cell 78 681-692.
39. RH Arch, RW Gedrich and CB Thompson (1998) Tumor necrosis factor receptor-associated factors (TRAFs) – a family of adapter proteins that regulates life and death. Genes Dev 12 2821-2830.
40. JY Chung, YC Park, H Ye and H Wu (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115 679-688.
41. H Wu (2004) Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily. Adv Protein Chem 68 225-279.
42. JY Chung, M Lu, Q Yin and H Wu (2007) Structural revelations of TRAF2 function in TNF receptor signaling pathway. Adv Exp Med Biol 597 93-113.
43. S Ghosh and M Karin (2002) Missing pieces in the NF-κB puzzle. Cell 109(Suppl.), S81-S96.
44. E Shaulian and M Karin (2002) AP-1 as a regulator of cell life and death. Nature Cell Biol 4 E131-E136.
45. S Nagata (1997) Apoptosis by death factor. Cell 88 355-365.
46. AM Chinnaiyan, K O’Rourke, M Tewari and VM Dixit (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 505-512.
47. MP Boldin, TM Goncharov, YV Goltsev and D Wallach (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85 803-815.
48. M Muzio, AM Chinnaiyan, FC Kischkel, K O’Rourke, A Shevchenko, J Ni, C Scaffidi, JD Bretz, M Zhang, R Gentz, M Mann, PH Krammer, ME Peter and VM Dixit (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85 817-827.
49. J Wang, HJ Chun, W Wong, DM Spencer and MJ Lenardo (2001) Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 98 13,884-13,888.
50. HN LeBlanc and A Ashkenazi (2003) Apo2L/TRAIL and its death and decoy receptors. Cell Death Diff 10 66-75.
51. H Hsu, H-B Shu, M-G Pan and DV Goeddel (1996) TRADD–TRAF2 and TRADD–FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84 299-308.
52. WC Yeh, A Shahinian, D Speiser, J Kraunus, F Billia, A Wakeham, JL de la Pompa, D Ferrick, B Hum, N Iscove, P Ohashi, M Rothe, DV Goeddel and TW Mak (1997) Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7 715-725.
53. MA Kelliher, S Grimm, Y Ishida, F Kuo, BZ Stanger and P Leder (1998) The death-domain kinase RIP mediates the TNF-induced NF-kB signal. Immunity 8 297-303.
54. O Micheau and J Tschopp (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 181-190.
55. JY Chung, M Lu, Q Yin, SC Lin and H Wu (2007) Molecular basis for the unique specificity of TRAF6. Adv Exp Med Biol 597 122-130.
56. HH Park, M Lu, Q Yin, SC Lin and H Wu (2007) The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunology 25 561-586.
57. HH Park, E Logette, S Rauser, S Cuenin, T Walz, J Tschopp and H Wu (2007) Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128 533-546.
58. TB Kepler and C Chan (2007) Spatiotemporal programming of a simple inflammatory process. Immunol Rev 216 153-163.
59. S Stojanov and MF McDermott (2005) The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med 7 1-18.
60. YX Fu and DD Chaplin (1999) Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 17 399-433.
61. WC Dougall, E Logette, S Rauser, S Cuenin, T Walz, J Tschopp and H Wu (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13 2412-2424.
62. YY Kong, H Yoshida, I Sarosi, HL Tan, E Timms, C Capparelli, S Morony, AJ Oliveira-dos-Santos, G Van, A Itie, W Khoo, A Wakeham, CR Dunstan, DL Lacey, TW Mak, WJ Boyle and JM Penninger (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 315-323.
63. D Kim, RE Mebius, JD MacMicking, S Jung, T Cupedo, Y Castellanos, J Rho, BR Wong, R Josien, N Kim, PD Rennert and Y Choi (2000) Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 192 1467-1478.
64. JE Fata, YY Kong, J Li, T Sasaki, J Irie-Sasaki, RA Moorehead, R Elliott, S Scully, EB Voura, DL Lacey, WJ Boyle, R Khokha and JM Penninger (2000) The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103 41-50.
65. DJ Headon and PA Overbeek (1999) Involvement of a novel TNF receptor homologue in hair follicle induction. Nature Genet 22 370-374.
66. AW Monreal, BM Ferguson, DJ Headon, SL Street, PA Overbeek and J Zonana (1999) Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia. Nature Genet 22 366-369.
67. NV Botchkareva, VA Botchkarev, LH Chen, G Lindner and R Paus (1999) A role for p75 neurotrophin receptor in the control of hair follicle morphogenesis. Dev Biol 216 135-153.
68. KF Lee, E Li, LJ Huber, SC Landis, AH Sharpe, MV Chao and R Jaenisch (1992) Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69 737-749.
69. M Bibel and YA Barde (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14 2919-2937.
70. F Martinon and J Tschopp (2005) NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26 447-454.
71. T Kawai and S Akira (2006) TLR signaling. Cell Death Diff 13 816-825.
72. RB Seth, L Sun and ZJ Chen (2006) Antiviral innate immunity pathways. Cell Res 16 141-147.
73. WC Yeh, R Hakem, M Woo and TW Mak (1999) Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling. Immunol Rev 169 283-302.
74. IS Grewal and RA Flavell (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16 111-135.
75. CL Cozine, KL Wolniak and TJ Waldschmidt (2005) The primary germinal center response in mice. Curr Opin Immunol 17 298-302.
76. T So, SW Lee and M Croft (2006) Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Intl J Hematol 83 1-11.
77. S Scheu, J Alferink, T Potzel, W Barchet, U Kalinke and K Pfeffer (2002) Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med 195 1613-1624.
78. S Nagata and P Golstein (1995) The Fas death factor. Science 267 1449-1456.
79. D Brenner, PH Krammer and R Arnold (2008) Concepts of activated T cell death. Crit Rev Oncol Hematol 66 52-64.
80. M Li and AA Beg (2000) Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol 74 7470-7477.
81. J Lam, S Takeshita, JE Barker, O Kanagawa, FP Ross and SL Teitelbaum (2000) TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106 1481-1488.
82. J Li, I Sarosi, XQ Yan, S Morony, C Capparelli, HL Tan, S McCabe, R Elliott, S Scully, G Van, S Kaufman, SC Juan, Y Sun, J Tarpley, L Martin, K Christensen, J McCabe, P Kostenuik, H Hsu, F Fletcher, CR Dunstan, DL Lacey and WJ Boyle (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97 1566-1571.
83. H Wu and JR Arron (2003) TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25 1096-1105.
84. LC Hofbauer, S Khosla, CR Dunstan, DL Lacey, TC Spelsberg and BL Riggs (1999) Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140 4367-4370.
85. S Cenci, MN Weitzmann, C Roggia, N Namba, D Novack, J Woodring and R Pacifici (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α. J Clin Invest 106 1229-1237.
86. MS Kim, SH Lee, MY Song, TH Yoo, BK Lee and YS Kim (2007) Comparative analyses of complex formation and binding sites between human tumor necrosis factor-alpha and its three antagonists elucidate their different neutralizing mechanisms. J Mol Biol 374 1374-1388.
87. U Fischer and K Schulze-Osthoff (2005) Apoptosis-based therapies and drug targets. Cell Death Diff 12(Suppl. 1), 942-961.
88. A Ashkenazi (2008) Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19 325-331.
89. PH Carter, PA Scherle, JK Muckelbauer, ME Voss, RQ Liu, LA Thompson, AJ Tebben, KA Solomon, YC Lo, Z Li, P Strzemienski, G Yang, N Falahatpisheh, M Xu, Z Wu, NA Farrow, K Ramnarayan, J Wang, D Rideout, V Yalamoori, P Domaille, DJ Underwood, JM Trzaskos, SM Friedman, RC Newton and CP Decicco (2001) Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α. Proc Natl Acad Sci USA 98 11,879-11,884.
90. S Fournel, S Wieckowski, W Sun, N Trouche, H Dumortier, A Bianco, O Chaloin, M Habib, JC Peter, P Schneider, B Vray, RE Toes, R Offringa, CJ Melief, J Hoebeke and G Guichard (2005) C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L. Nature Chem Biol 1 377-382.
91. MM He, AS Smith, JD Oslob, WM Flanagan, AC Braisted, A Whitty, MT Cancilla, J Wang, AA Lugovskoy, JC Yoburn, AD Fung, G Farrington, JK Eldredge, ES Day, LA Cruz, TG Cachero, SK Miller, JE Friedman, IC Choong and BC Cunningham (2005) Small-molecule inhibition of TNF-α. Science 310 1022-1025.
92. R Murali, AS Smith, JD Oslob, WM Flanagan, AC Braisted, A Whitty, MT Cancilla, J Wang, AA Lugovskoy, JC Yoburn, AD Fung, G Farrington, JK Eldredge, ES Day, LA Cruz, TG Cachero, SK Miller, JE Friedman, IC Choong and BC Cunningham (2005) Disabling TNF receptor signaling by induced conformational perturbation of tryptophan–107. Proc Natl Acad Sci USA 102 10,970-10,975.
93. N Trouche, S Wieckowski, W Sun, O Chaloin, J Hoebeke, S Fournel and G Guichard (2007) Small multivalent architectures mimicking homotrimers of the TNF superfamily member CD40L: delineating the relationship between structure and effector function. J Am Chem Soc 129 13,480-13,492.
94. H Ye, JR Arron, B Lamothe, M Cirilli, T Kobayashi, NK Shevde, D Segal, OK Dzivenu, M Vologodskaia, M Yim, K Du, S Singh, JW Pike, BG Darnay, Y Choi and H Wu (2002) Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418 443-447.
95. H Wu, J Tschopp and SC Lin (2007) Smac mimetics and TNF-α: a dangerous liaison? Cell 131 655-658.
96. SL Petersen, L Wang, A Yalcin-Chin, L Li, M Peyton, J Minna, P Harran and X Wang (2007) Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12 445-456.
97. JE Vince, WW Wong, N Khan, R Feltham, D Chau, AU Ahmed, CA Benetatos, SK Chunduru, SM Condon, M McKinlay, R Brink, M Leverkus, V Tergaonkar, P Schneider, BA Callus, F Koentgen, DL Vaux and J Silke (2007) IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131 682-693.
98. E Varfolomeev, JW Blankenship, SM Wayson, AV Fedorova, N Kayagaki, P Garg, K Zobel, JN Dynek, LO Elliott and HJ Wallwebe (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131 669-681.
99. EY Jones, DI Stuart and NP Walker (1989) Structure of tumour necrosis factor. Nature 338 225-228.
100. MJ Eck and SR Sprang (1989) The structure of tumor necrosis factor-alpha at 2.6Å resolution. Implications for receptor binding. J Biol Chem 264 17,595-17,605.
101. SS Cha, JS Kim, HS Cho, NK Shin, W Jeong, HC Shin, YJ Kim, JH Hahn and BH Oh (1998) High resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicity. J Biol Chem 273 2153-2160.
102. C Reed, ZQ Fu, J Wu, YN Xue, RW Harrison, MJ Chen and IT Weber (1997) Crystal structure of TNF-α mutant R31D with greater affinity for receptor R1 compared with R2. Protein Eng 10 1101-1107.
103. M Karpusas, YM Hsu, JH Wang, J Thompson, S Lederman, L Chess and D Thomas (1995) 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3 1031-1039.
104. M Karpusas, J Lucci, J Ferrant, C Benjamin, FR Taylor, K Strauch, E Garber and YM Hsu (2001) Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody. Structure 9 321-329.
105. SS Cha, MS Kim, YH Choi, BJ Sung, NK Shin, HC Shin, YC Sung and BH Oh (1999) 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11 253-261.
106. SG Hymowitz, MP O’Connell, MH Ultsch, A Hurst, K Totpal, A Ashkenazi, AM de Vos and RF Kelley (2000) A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 39 633-640.
107. J Lam, CA Nelson, FP Ross, SL Teitelbaum and DH Fremont (2001) Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. J Clin Invest 108 971-979.
108. S Ito, K Wakabayashi, O Ubukata, S Hayashi, F Okada and T Hata (2002) Crystal structure of the extracellular domain of mouse RANK ligand at 2.2-A resolution. J Biol Chem 277 6631-6636.
109. T Jin, K Wakabayashi, O Ubukata, S Hayashi, F Okada and T Hata (2007) X-ray crystal structure of TNF ligand family member TL1A at 2.1 Å. Biochem Biophys Res Commun 364 1-6.
110. Z Zhou, K Wakabayashi, O Ubukata, S Hayashi, F Okada and T Hata (2008) Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states. Proc Natl Acad Sci USA 105 5465-5470.
111. JH Naismith, TQ Devine, BJ Brandhuber and SR Sprang (1995) Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J Biol Chem 270 13,303-13,307.
112. JH Naismith, TQ Devine, T Kohno and SR Sprang (1996) Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4 1251-1262.
113. FA Fellouse, B Li, DM Compaan, AA Peden, SG Hymowitz and SS Sidhu (2005) Molecular recognition by a binary code. J Mol Biol 348 1153-1162.
114. B Li, SJ Russell, DM Compaan, K Totpal, SA Marsters, A Ashkenazi, AG Cochran, SG Hymowitz and SS Sidhu (2006) Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists. J Mol Biol 361 522-536.
115. A Carfi, SH Willis, JC Whitbeck, C Krummenacher, GH Cohen, RJ Eisenberg and DC Wiley (2001) Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell 8 169-179.
116. DM Compaan, LC Gonzalez, I Tom, KM Loyet, D Eaton and SG Hymowitz (2005) Attenuating lymphocyte activity: the crystal structure of the BTLA–HVEM complex. J Biol Chem 280 39,553-39,561.
117. XL He and KC Garcia (2004) Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304 870-875.
118. Y Gong, P Cao, HJ Yu and T Jiang (2008) Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex. Nature 454 789-793.